According to Rain Therapeutics's latest financial reports the company's current EPS (TTM) is -$2.55. In 2022 the company made an earnings per share (EPS) of -$2.70 a decrease over its 2021 EPS that were of -$2.03.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$2.55 | -5.56% |
2022 | -$2.70 | 32.88% |
2021 | -$2.03 | 2.71% |
2020 | -$1.98 |